Dr. Mohan J Durve , MD
Specialist • Parma, OH
6681 Ridge Rd Ste 305
Parma, OH 441295705
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 10, 2006; this date does not establish years in practice.
-
Published CMS data list 14,472 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2357 — Injection, omalizumab, 5 mg: 6,780 service units.
- 95165 — Professional service for preparation and provision of 1 or more antigens: 3,623 service units.
- 95004 — Test for allergy using allergenic extract: 1,824 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 11 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,012 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Montelukast Sodium — 187 prescription fills, including refills.
- Fluticasone Propionate — 163 prescription fills, including refills.
- Azelastine Hcl — 101 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: 744. Middle half: 216 to 2,030.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 16,362 in 2020 to 14,472 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
6681 Ridge Rd Ste 305
Parma, OH 441295705
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
1971
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
67 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $353,746 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $279,463 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,584 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$530,897 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $4,126.27 across 112 records.
By nature of payment
- Food and Beverage: $4,092.27 across 111 records.
- Education: $34.00 across 1 record.
Reporting-company totals (3 largest of 20)
- GlaxoSmithKline, LLC.: $698.01 across 26 records.
- Novartis Pharmaceuticals Corporation: $642.72 across 23 records.
- Genentech, Inc.: $642.68 across 9 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
55 years (graduated 1971)
CMS Doctors and Clinicians data list 1971 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Durve has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Durve as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Parma and Ohio
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: 744. Middle half: 216 to 2,030.
Too few clinicians listed under Specialist in Parma have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 85% of clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: $55,907. Middle half: $22,244 to $144,453.
Too few clinicians listed under Specialist in Parma have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 85% of clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: $41,063. Middle half: $16,532 to $104,577.
Too few clinicians listed under Specialist in Parma have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: 518. Middle half: 102 to 1,924.
Too few clinicians listed under Specialist in Parma have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 80% of clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: $66,137. Middle half: $1,855 to $302,101.
Too few clinicians listed under Specialist in Parma have Medicare Part D data for 2024 to compare.
9 active clinicians are listed under Specialist with a practice address in Parma, OH (1,313 in Ohio).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 12% from 16,362 in 2020 to 14,472 in 2024.
- 2020: 16,362
- 2021: 9,558
- 2022: 9,360
- 2023: 8,461
- 2024: 14,472
-
Medicare-allowed amount
Medicare-allowed amount decreased 12% from $403,427 in 2020 to $353,746 in 2024.
- 2020: $403,427
- 2021: $160,104
- 2022: $155,194
- 2023: $135,198
- 2024: $353,746
-
Paid by Medicare
Paid by Medicare decreased 12% from $317,895 in 2020 to $279,463 in 2024.
- 2020: $317,895
- 2021: $125,371
- 2022: $119,725
- 2023: $104,242
- 2024: $279,463
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 10% from 1,127 in 2020 to 1,012 in 2024.
- 2020: 1,127
- 2021: 1,093
- 2022: 1,021
- 2023: 854
- 2024: 1,012
-
30-day fills
30-day fills stayed about the same: 1,605 in 2020 and 1,584 in 2024.
- 2020: 1,605
- 2021: 1,607
- 2022: 1,535
- 2023: 1,404
- 2024: 1,584
-
Part D drug cost
Part D drug cost increased 34% from $396,137 in 2020 to $530,897 in 2024.
- 2020: $396,137
- 2021: $407,087
- 2022: $464,860
- 2023: $481,655
- 2024: $530,897
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 26% from $5,596.12 in 2021 to $4,126.27 in 2025.
- 2021: $5,596.12
- 2022: $5,358.82
- 2023: $9,233.36
- 2024: $3,384.27
- 2025: $4,126.27
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 112 records totaling $4,126.27.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
— | General | $150.23 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $131.49 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $130.94 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $128.68 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $125.00 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
— | General | $120.21 |
| BioCryst Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ORLADEYO | General | $118.25 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $115.78 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
— | General | $115.04 |
| CSL Behring |
Food and Beverage
In-kind items and services
|
Andembry | General | $113.55 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $112.31 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
WAYRILZ | General | $111.21 |
| Verona Pharma, Inc. |
Food and Beverage
Cash or cash equivalent
|
Ohtuvayre | General | $110.32 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $109.51 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Rhapsido | General | $108.85 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
— | General | $103.47 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $102.53 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $101.90 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
AREXVY | General | $100.44 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $100.02 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
— | General | $98.50 |
| CSL Behring |
Food and Beverage
In-kind items and services
|
Andembry | General | $87.86 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $87.16 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $83.52 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $64.51 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2357
Injection, omalizumab, 5 mg
|
6,780 | 12 | $40.14 | $35.85 |
|
95165
Professional service for preparation and provision of 1 or more antigens
|
3,623 | 41 | $26.00 | $13.31 |
|
95004
Test for allergy using allergenic extract
|
1,824 | 24 | $9.49 | $3.35 |
|
95024
Test for allergy using allergenic extract injected into skin
|
641 | 24 | $12.44 | $7.22 |
|
95117
Professional service for multiple injections of allergen
|
588 | 42 | $43.00 | $11.05 |
|
96372
Injection of drug or substance under skin or into muscle
|
266 | 17 | $112.00 | $13.33 |
|
94060
Test to measure expiratory airflow and volume changes before and after medication administration
|
212 | 35 | $140.00 | $35.53 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
212 | 51 | $138.00 | $85.40 |
|
95012
Test to measure the level of nitric oxide gas
|
204 | 35 | $40.00 | $17.00 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
90 | 42 | $225.00 | $120.90 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
32 | 14 | $107.00 | $52.90 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Montelukast Sodium | Montelukast Sodium | 187 | 11,370 | $1,483.73 | 63 |
| Fluticasone Propionate | Fluticasone Propionate | 163 | 8,415 | $1,987.09 | 52 |
| Azelastine Hcl | Azelastine Hcl | 101 | 4,885 | $2,487.17 | 37 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 84 | 3,722 | $2,947.13 | 36 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 71 | 2,940 | $62,062.12 | 26 |
| Breo Ellipta | Fluticasone/Vilanterol | 58 | 2,670 | $35,290.24 | 12 |
| Prednisone | Prednisone | 50 | 467 | $179.66 | 33 |
| Xolair | Omalizumab | 36 | 1,034 | $153,917.30 | — |
| Tezspire | Tezepelumab-Ekko | 34 | 952 | $140,012.52 | — |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 32 | 1,560 | $132.41 | — |
| Mometasone Furoate | Mometasone Furoate | 27 | 900 | $596.33 | 14 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 24 | 840 | $16,390.31 | — |
| Azithromycin | Azithromycin | 23 | 115 | $72.33 | 18 |
| Nucala | Mepolizumab | 23 | 806 | $105,302.68 | — |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | 570 | $173.54 | — |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | 1,140 | $382.04 | — |
| Omeprazole | Omeprazole | 14 | 780 | $12.45 | — |
| Doxepin Hcl | Doxepin Hcl | 14 | 413 | $341.54 | — |
| Ipratropium Bromide | Ipratropium Bromide | 13 | 714 | $261.82 | — |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | 742 | $142.21 | — |
| Xhance | Fluticasone Propionate | 11 | 330 | $6,722.61 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-08-11NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - ALLERGY/IMMUNOLOGY
I20120204000015
OH
7911998638
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 6681 RIDGE RD STE 305, PARMA, OH 441295705 (Tel: 4408457272)
NPI status registered as active in NPPES database
Registered at 6115 POWERS BLVD, 202, PARMA, OH 441295471 (Tel: 4408457272)
Registered at 6681 RIDGE RD, STE 305, PARMA, OH 441295705 (Tel: 4408457272)
Recorded as MOHAN DURVE, MD
Specialist (license number reported to NPPES: OH 35041028)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
More public profiles in Ohio
Directory navigation, in NPI number order.
- Ankur Girdhar, MD Internal Medicine - Pulmonary Disease · Fairfield
- Stacy Whisner, CNP Nurse Practitioner - Family · Columbus
- Charles Justice, CRNA Nurse Anesthetist, Certified Registered · Akron
- Shawna Koprucki, MD Family Medicine · Youngstown
- Muhammad Bawany, MD Internal Medicine - Gastroenterology · West Chester
- Paul Kozy, DDS Dentist - General Practice · Toledo
- Jocelyn Pettitt, OD Optometrist · Mentor
- Bilal Ahmed, DDS Dentist - General Practice · Mason
- Olugbenga Olowokure, MD Internal Medicine - Medical Oncology · West Chester
- Deepak Krishnan, DDS Oral & Maxillofacial Surgery · Cincinnati
- Ariane Park, MD Psychiatry & Neurology - Neurology · Gahanna
- Jeremy Joseph, DDS Dentist - General Practice · Highland Heights
Mailing Address
6681 Ridge Rd, Ste 305
Parma, OH 441295705
Phone: 4408457272